X0708 D LIVE 0001691082 LB PHARMACEUTICALS INC 575 MADISON AVENUE NEW YORK NY NEW YORK 10022 212-605-0230 DELAWARE LB PHARMACEUTICALS INC. Corporation true Zachary Prensky 575 Madison Avenue New York NY NEW YORK 10022 Executive Officer Director Robert Ruffolo 575 Madison Avenue New York NY NEW YORK 10022 Director Rebecca Luse 575 Madison Avenue New York NY NEW YORK 10022 Director Rajul Jain 575 Madison Avenue New York NY NEW YORK 10022 Director Ran Nussbaum 575 Madison Avenue New York NY NEW YORK 10022 Director Simon Basseyn 575 Madison Avenue New York NY NEW YORK 10022 Director Marc Panoff 575 Madison Avenue New York NY NEW YORK 10022 Executive Officer Anna Eramo 575 Madison Avenue New York NY NEW YORK 10022 Executive Officer Andrew Vaino 575 Madison Avenue New York NY NEW YORK 10022 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2023-08-29 false true true false 0 Maxim Group LLC 120708 None None 300 Park Avenue 16th Floor New York NY NEW YORK 10022 All States true Agile Capital Markets None Agile Capital Markets None 33 rue Lafayette Paris I0 FRANCE 75009 true 110730354 70730354 40000000 The total offering amount of $110,730,354 consists of $75,000,000 new cash offering and $35,730,354 automatic conversion of existing convertible notes, for which notes (including underlying securities) a Form D was previously filed upon the original sale. false 6 1150333 343000 1180000 false LB PHARMACEUTICALS INC Zachary Prensky Zachary Prensky Chief Executive Officer 2023-09-21